Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
暂无分享，去创建一个
C. Loprinzi | A. Grothey | S. Dakhil | L. Fehrenbacher | R. Qin | P. Atherton | D. Seisler | R. Qamar | Kathleen A. Flynn | Grant C. Lewis | G. C. Lewis | Drew K. Seisler